Trial Profile
Pegylated interferon therapy for acute hepatitis C infection in HIV-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 20 Oct 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 20 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2006 New trial record.